Induced Pluripotent Stem Cells from Familial Alzheimer's Disease Patients Differentiate into Mature Neurons with Amyloidogenic Properties

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Stem Cells and Development

• Publication date

  2014-07-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1089/scd.2013.0511PMID 25027006PMCID PMC4267410
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Modeling Alzheimer's disease with iPSCs reveals stress phenotypes associated with intracellular Aβ and differential drug responsiveness.

  2013cited by this paper
• Growth Factor-Activated Stem Cell Circuits and Stromal Signals Cooperatively Accelerate Non-Integrated iPSC Reprogramming of Human Myeloid Progenitors

  2012cited by this paper
• Sequences Human Induced Pluripotent Stem Cells Free of Vector and Transgene

  2012influential reference
• Probing sporadic and familial Alzheimer’s disease using induced pluripotent stem cells

  2012cited by this paper
• Small‐molecule inhibitors of bone morphogenic protein and activin/nodal signals promote highly efficient neural induction from human pluripotent stem cells

  2011cited by this paper
• A Universal System for Highly Efficient Cardiac Differentiation of Human Induced Pluripotent Stem Cells That Eliminates Interline Variability

  2011cited by this paper
• Modeling familial Alzheimer's disease with induced pluripotent stem cells.

  2011cited by this paper
• Generation of Nonviral Integration-Free Induced Pluripotent Stem Cells from Plucked Human Hair Follicles

  2011influential reference
• Integration-free induced pluripotent stem cells derived from schizophrenia patients with a DISC1 mutation

  2011cited by this paper
• Capturing Alzheimer's disease genomes with induced pluripotent stem cells: prospects and challenges

  2011cited by this paper
• Induced pluripotent stem cells: a new revolution for clinical neurology?

  2011cited by this paper
• A functionally characterized test set of human induced pluripotent stem cells

  2011cited by this paper
• Neocortical layer formation of human developing brains and lissencephalies: consideration of layer-specific marker expression.

  2011cited by this paper
• gamma-secretases: from cell biology to therapeutic strategies.

  2010cited by this paper
• Characterization of Human Huntington's Disease Cell Model from Induced Pluripotent Stem Cells

  2010cited by this paper
• Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency

  2010cited by this paper
• The Nun Study

  2009cited by this paper
• Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling

  2009cited by this paper
• Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors.

  2009cited by this paper
• Coordination of sonic hedgehog and Wnt signaling determines ventral and dorsal telencephalic neuron types from human embryonic stem cells

  2009cited by this paper
• The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics

  2009cited by this paper
• Induced pluripotent stem cells generated without viral integration

  2009cited by this paper
• Long‐Term, Stable Differentiation of Human Embryonic Stem Cell‐Derived Neural Precursors Grafted into the Adult Mammalian Neostriatum

  2009cited by this paper
• Faculty Opinions recommendation of Human induced pluripotent stem cells free of vector and transgene sequences.

  2009cited by this paper
• Human Induced Pluripotent Stem Cells Free of Vector and Transgene Sequences

  2009cited by this paper
• Reprogramming of human somatic cells to pluripotency with defined factors

  2008cited by this paper
• Induced Pluripotent Stem Cells Generated from Patients with ALS Can Be Differentiated into Motor Neurons

  2008cited by this paper
• Self-organized formation of polarized cortical tissues from ESCs and its active manipulation by extrinsic signals.

  2008cited by this paper
• Linking Abeta and tau in late-onset Alzheimer's disease: a dual pathway hypothesis.

  2008cited by this paper
• Inhibition of Activin/Nodal signaling promotes specification of human embryonic stem cells into neuroectoderm.

  2008cited by this paper
• Human ES cell-derived neural rosettes reveal a functionally distinct early neural stem cell stage.

  2008cited by this paper
• Induced Pluripotent Stem Cells Generated Without Viral Integration

  2008cited by this paper
• Generation of Mouse Induced Pluripotent Stem Cells Without Viral Vectors

  2008cited by this paper
• Why myc? An unexpected ingredient in the stem cell cocktail.

  2008cited by this paper
• Noggin Enhances Dopamine Neuron Production from Human Embryonic Stem Cells and Improves Behavioral Outcome After Transplantation into Parkinsonian Rats

  2008cited by this paper
• When loss is gain: reduced presenilin proteolytic function leads to increased Aβ42/Aβ40

  2007cited by this paper
• When loss is gain: reduced presenilin proteolytic function leads to increased Abeta42/Abeta40. Talking Point on the role of presenilin mutations in Alzheimer disease.

  2007cited by this paper
• Strategies and new developments in the generation of patient-specific pluripotent stem cells.

  2007cited by this paper
• Generation of germline-competent induced pluripotent stem cells

  2007cited by this paper
• Improved Human Embryonic Stem Cell Embryoid Body Homogeneity and Cardiomyocyte Differentiation from a Novel V‐96 Plate Aggregation System Highlights Interline Variability

  2007cited by this paper
• Emerging role of KLF4 in human gastrointestinal cancer.

  2006cited by this paper
• Presenilin clinical mutations can affect γ‐secretase activity by different mechanisms

  2006cited by this paper
• Forced aggregation of defined numbers of human embryonic stem cells into embryoid bodies fosters robust, reproducible hematopoietic differentiation.

  2005cited by this paper
• Early life linguistic ability, late life cognitive function, and neuropathology: findings from the Nun Study.

  2005cited by this paper
• Deciphering the molecular basis of memory failure in Alzheimer's disease.

  2004cited by this paper
• Transplantation of Human Embryonic Stem Cell–Derived Neural Progenitors Improves Behavioral Deficit in Parkinsonian Rats

  2004cited by this paper
• Regulation of human embryonic stem cell differentiation by BMP-2 and its antagonist noggin

  2004cited by this paper
• Does my mouse have Alzheimer's disease?

  2002cited by this paper
• gamma-Secretase, Notch, Abeta and Alzheimer's disease: where do the presenilins fit in?

  2002cited by this paper
• γ-Secretase, notch, Aβ and alzheimer's disease: Where do the presenilins fit in?

  2002cited by this paper
• The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics

  2002cited by this paper
• Genetically engineered mouse models of neurodegenerative diseases

  2002cited by this paper
• Presenilin, Notch, and the genesis and treatment of Alzheimer's disease

  2001cited by this paper
• In vitro differentiation of transplantable neural precursors from human embryonic stem cells

  2001cited by this paper
• Feeder-free growth of undifferentiated human embryonic stem cells

  2001cited by this paper
• High-Level Neuronal Expression of Aβ1–42 in Wild-Type Human Amyloid Protein Precursor Transgenic Mice: Synaptotoxicity without Plaque Formation

  2000cited by this paper
• Embryonic stem cell lines derived from human blastocysts.

  1998cited by this paper
• Genetic neurodegenerative diseases: the human illness and transgenic models.

  1998cited by this paper
• Estimation of the genetic contribution of presenilin-1 and -2 mutations in a population-based study of presenile Alzheimer disease.

  1998cited by this paper
• The E280A presenilin 1 Alzheimer mutation produces increased Aβ42 deposition and severe cerebellar pathology

  1996cited by this paper
• Secreted amyloid β–protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease

  1996cited by this paper
• Mechanisms of neuronal degeneration in Alzheimer's disease.

  1996cited by this paper
• Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease.

  1996cited by this paper
• Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease

  1995influential reference
• Age at onset of Alzheimer's disease

  1994cited by this paper
• Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease.

  1989cited by this paper
• über eigenartige Krankheitsfälle des späteren Alters

  1911cited by this paper

• Modeling neurovascular dysfunction in Alzheimer’s disease using an isogenic brain-chip model

  2026cites this paper
• Stem cell and CRISPR/Cas9 gene editing technology in Alzheimer’s disease therapy: from basic research to clinical innovation

  2025cites this paper
• Multi‐Region Brain Organoids Integrating Cerebral, Mid‐Hindbrain, and Endothelial Systems

  2025cites this paper
• Vascular models of Alzheimer's disease: An overview of recent in vitro models of the blood-brain barrier.

  2025cites this paper
• The role of machine learning in discovering biomarkers and predicting treatment strategies for neurodegenerative diseases: A narrative review

  2025cites this paper
• Alzheimer’s disease induced neurons bearing PSEN1 mutations exhibit reduced excitability

  2024influential citation
• Mutual interaction of neurons and astrocytes derived from iPSCs with APP V717L mutation developed the astrocytic phenotypes of Alzheimer’s disease

  2024cites this paper
• Simple modeling of familial Alzheimer’s disease using human pluripotent stem cell-derived cerebral organoid technology

  2024cites this paper
• Modeling Alzheimer's Disease using Cerebral Organoids: Current Challenges and Prospects

  2024cites this paper
• Proteomic Approach Using DIA-MS Identifies Morphogenesis-Associated Proteins during Cardiac Differentiation of Human iPS Cells

  2024cites this paper
• Quantitative Proteomics for the Development and Manufacturing of Human-Induced Pluripotent Stem Cell-Derived Neural Stem Cells Using Data-Independent Acquisition Mass Spectrometry

  2023cites this paper
• Excitatory Neurons Derived from Human-Induced Pluripotent Stem Cells Show Transcriptomic Differences in Alzheimer’s Patients from Controls

  2023cites this paper
• Developmental Pb exposure increases AD risk via altered intracellular Ca2+ homeostasis in hiPSC-derived cortical neurons

  2023cites this paper
• Effect and Potential Mechanism of Immunotherapy on Cognitive Deficits in Animal Models of Alzheimer's Disease: A Systematic Review and Meta-Analysis.

  2023cites this paper
• Insights for disease modeling from single-cell transcriptomics of iPSC-derived Ngn2-induced neurons and astrocytes across differentiation time and co-culture

  2023cites this paper
• The Breakthroughs and Caveats of Using Human Pluripotent Stem Cells in Modeling Alzheimer’s Disease

  2023influential citation
• An insight into the iPSCs-derived two-dimensional culture and three-dimensional organoid models for neurodegenerative disorders

  2022cites this paper
• Induced pluripotent stem cell-derived and directly reprogrammed neurons to study neurodegenerative diseases: The impact of aging signatures

  2022cites this paper
• Unraveling pathological mechanisms in neurological disorders: the impact of cell-based and organoid models

  2022cites this paper
• Human iPSC-Derived Neural Models for Studying Alzheimer’s Disease: from Neural Stem Cells to Cerebral Organoids

  2022cites this paper
• Insights for disease modeling from single cell transcriptomics of iPSC

  2022cites this paper
• Stem cell-derived three-dimensional (organoid) models of Alzheimer’s disease: a precision medicine approach

  2021cites this paper
• CRISPR-activated patient fibroblasts for modeling of familial Alzheimer's disease.

  2021cites this paper
• Optimization of cerebral organoids: a more qualified model for Alzheimer’s disease research

  2021cites this paper
• The path to progress preclinical studies of age-related neurodegenerative diseases: A perspective on rodent and hiPSC-derived models.

  2021cites this paper
• Mass spectrometry analysis of tau and amyloid‐beta in iPSC‐derived models of Alzheimer’s disease and dementia

  2021cites this paper
• Hypothesis and Theory: Characterizing Abnormalities of Energy Metabolism Using a Cellular Platform as a Personalized Medicine Approach for Alzheimer’s Disease

  2021cites this paper
• Harnessing cerebral organoids for Alzheimer's disease research.

  2021cites this paper
• Using induced pluripotent stem cell neuronal models to study neurodegenerative diseases.

  2020cites this paper
• Precision Medicine in Neurology: The Inspirational Paradigm of Complement Therapeutics

  2020cites this paper
• Stem Cell Therapy for Alzheimer's Disease.

  2020cites this paper
• Collagen hydrogel confinement of Amyloid-β (Aβ) accelerates aggregation and reduces cytotoxic effects.

  2020cites this paper
• Chromatin Interaction Changes during the iPSC-NPC Model to Facilitate the Study of Biologically Significant Genes Involved in Differentiation

  2020cites this paper
• Neural Stem Cells and Methods for Their Generation From Induced Pluripotent Stem Cells in vitro

  2020cites this paper
• Stem cell therapy for Alzheimer's disease

  2020cites this paper
• A Three-Dimensional Alzheimer’s Disease Cell Culture Model Using iPSC-Derived Neurons Carrying A246E Mutation in PSEN1

  2020cites this paper
• iPSCs from people with MS can differentiate into oligodendrocytes in a homeostatic but not an inflammatory milieu

  2020cites this paper
• The Use of Patient-Derived Induced Pluripotent Stem Cells for Alzheimer's Disease Modeling.

  2020cites this paper
• Live cell imaging of single neurotrophin receptor molecules on human neuron in Alzheimer’s disease

  2020cites this paper
• iPSCs-derived nerve-like cells from familial Alzheimer's disease PSEN 1 E280A reveal increased amyloid-beta levels and loss of the Y chromosome.

  2019cites this paper
• Human iPSC-derived blood-brain barrier microvessels: validation of barrier function and endothelial cell behavior.

  2019cites this paper
• Human iPSC application in Alzheimer's disease and Tau-related neurodegenerative diseases.

  2019cites this paper
• Stem Cell-Derived Neurons as Cellular Models of Sporadic Alzheimer’s Disease

  2019cites this paper
• Important advances in Alzheimer’s disease from the use of induced pluripotent stem cells

  2019cites this paper
• Highly Purified Human Extracellular Vesicles Produced by Stem Cells Alleviate Aging Cellular Phenotypes of Senescent Human Cells

  2019cites this paper
• Studying Human Neurological Disorders Using Induced Pluripotent Stem Cells: From 2D Monolayer to 3D Organoid and Blood Brain Barrier Models.

  2019cites this paper
• The Use of Pluripotent Stem Cell-Derived Organoids to Study Extracellular Matrix Development during Neural Degeneration

  2019cites this paper
• Familial Alzheimer’s disease patient-derived neurons reveal distinct mutation-specific effects on amyloid-beta

  2019cites this paper
• Amyloid formation and metabolism in induced pluripotent stem cell derived neural models

  2019influential citation
• Modelling mitochondrial dysfunction in Alzheimer’s disease using human induced pluripotent stem cells

  2019cites this paper
• The role of mutations associated with familial neurodegenerative disorders on blood–brain barrier function in an iPSC model

  2019cites this paper
• Collagen hydrogel confinement of amyloid-β accelerates aggregation and reduces cytotoxic effects

  2019cites this paper
• Calcilytic NPS 2143 Reduces Amyloid Secretion and Increases sAβPPα Release from PSEN1 Mutant iPSC-Derived Neurons

  2019cites this paper
• Optogenetically transduced human ES cell-derived neural progenitors and their neuronal progenies: Phenotypic characterization and responses to optical stimulation

  2019cites this paper
• Episomal Induced Pluripotent Stem Cells: Functional and Potential Therapeutic Applications

  2019cites this paper
• The application of patient-derived induced pluripotent stem cells for modeling and treatment of Alzheimer’s disease

  2019cites this paper
• Use of iPSCs for the treatment of neurodegenerative diseases

  2019cites this paper
• Genetics of Alcohol Use Disorder: A Role for Induced Pluripotent Stem Cells?

  2018cites this paper
• Astrocyte-enriched feeder layers from cryopreserved cells support differentiation of spontaneously active networks of human iPSC-derived neurons.

  2018cites this paper
• Génération de cellules souches pluripotentes induites de patients Alzheimer et production d'un modèle de culture en trois dimensions de neurones pour les recherches diagnostiques et thérapeutiques de la maladie d’Alzheimer

  2018influential citation
• Functional brain-specific microvessels from iPSC-derived human brain microvascular endothelial cells: the role of matrix composition on monolayer formation

  2018cites this paper
• A simple and efficient feeder-free culture system to up-scale iPSCs on polymeric material surface for use in 3D bioprinting.

  2018cites this paper
• Representing Diversity in the Dish: Using Patient-Derived in Vitro Models to Recreate the Heterogeneity of Neurological Disease

  2018cites this paper
• DNA Damage Response and Repair, DNA Methylation, and Cell Death in Human Neurons and Experimental Animal Neurons Are Different

  2018cites this paper
• 3D human brain cell models: New frontiers in disease understanding and drug discovery for neurodegenerative diseases.

  2018cites this paper
• Modeling amyloid beta and tau pathology in human cerebral organoids

  2018cites this paper
• Characteristic analyses of a neural differentiation model from iPSC-derived neuron according to morphology, physiology, and global gene expression pattern

  2017cites this paper
• Induced pluripotent stem cells as a discovery tool for Alzheimer׳s disease.

  2017cites this paper
• Multi-level characterization of balanced inhibitory-excitatory cortical neuron network derived from human pluripotent stem cells

  2017cites this paper
• CRISPR Transcriptional Activation Analysis Unmasks an Occult γ-Secretase Processivity Defect in Familial Alzheimer's Disease Skin Fibroblasts.

  2017cites this paper
• Comparative performance analysis of human iPSC-derived and primary neural progenitor cells (NPC) grown as neurospheres in vitro.

  2017cites this paper
• Stem cell models of Alzheimer’s disease: progress and challenges

  2017cites this paper
• CRISPR/Cas9-Correctable mutation-related molecular and physiological phenotypes in iPSC-derived Alzheimer’s PSEN2N141I neurons

  2017cites this paper
• Induced Pluripotent Stem Cell Therapy and Safety Concerns in Age-Related Chronic Neurodegenerative Diseases

  2017cites this paper
• Could Stem Cells Be Used to Treat or Model Alzheimer’s Disease?

  2016cites this paper
• Induced pluripotent stem cell technology: a decade of progress

  2016cites this paper
• Modelling Neurodegenerative Diseases Using Human Pluripotent Stem Cells

  2016cites this paper
• A hybrid microfluidic system for regulation of neural differentiation in induced pluripotent stem cells.

  2016cites this paper
• Gr upSM Human Induced Pluripotent Stem Cells and their Derivatives for Disease Modeling and Therapeutic Applications in Alzheimer ’ s Disease

  2016influential citation
• Design, synthesis and biological evaluation of small molecules for controlling cellular development

  2016cites this paper
• iPSCs: On the Road to Reprogramming Aging.

  2016cites this paper
• Extracellular vesicle-associated Aβ mediates trans-neuronal bioenergetic and Ca2+-handling deficits in Alzheimer’s disease models

  2016cites this paper
• The potential of induced pluripotent stem cells in models of neurological disorders: implications on future therapy

  2015cites this paper
• Induced pluripotent stem cell technology for modelling and therapy of cerebellar ataxia

  2015cites this paper
• Cellular models to study bipolar disorder: A systematic review.

  2015cites this paper
• Research progress in animal models and stem cell therapy for Alzheimer’s disease

  2014cites this paper
• Representing Diversity In The Dish: Using Patient-Derived In Vitro Representing Diversity In The Dish: Using Patient-Derived In Vitro Models To Recreate The Heterogeneity Of Neurological Disease Models To Recreate The Heterogeneity Of Neurological Disease

  year unknowncites this paper